MBX Biosciences, Inc. MBX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $45.21M-39.9% | $75.29M-66.3% | $223.13M+461% | $39.78M— | —— | ||
| $394.76M+32.3% | $298.42M+77.1% | $168.55M-9.0% | $185.13M— | —— | ||
| $448.54M+17.6% | $381.54M-4.0% | $397.5M+73.4% | $229.19M— | —— | ||
| $3.13M+14.6% | $2.74M+36.5% | $2M+15.8% | $1.73M— | —— | ||
| $452.7M+17.5% | $385.14M-3.7% | $400.08M+72.8% | $231.52M— | —— | ||
| $19.48M+16.3% | $16.75M-12.3% | $19.11M-6.1% | $20.35M+34.2% | $15.16M+33.1% | ||
| $14.57M-6.0% | $15.5M+28.5% | $12.06M+2.6% | $11.76M— | —— | ||
| $14.95M-6.1% | $15.92M+27.0% | $12.54M+2.1% | $12.28M— | —— | ||
| $6K0.0% | $6K0.0% | $6K+20.0% | $5K— | —— | ||
| -$247.99M-10.5% | -$224.48M-10.9% | -$202.41M-12.0% | -$180.8M— | —— | ||
| $437.76M+18.6% | $369.22M-4.7% | $387.54M+76.8% | $219.24M-6.9% | $235.42M-8.6% | ||
| $452.7M+17.5% | $385.14M-3.7% | $400.08M+72.8% | $231.52M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can MBX Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 30.79 — current assets exceed current liabilities.
- Where does MBX Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.